Recent Posts

The failure here is not the recent performance that resulted in the stock decline but rather the decisions that were made years ago that severely underestimated the potential of semaglutide in obesity. Had the company really known what they had, we wouldn’t be in the no-win situation we are in now.

We would’ve had supply from the start. We would gained preference earlier. It would have taken years not months for Zepbound to take over.

Lars himself admitted as much a couple years ago during the peak of our supply issues. We are a diabetes company and we looked at Wegovy and obesity as a nice little add on. We totally underestimated the paradigm shifting potential that GLP-1 had.

Since that decision we made mis-step after mis-step. We thought our way of doing it was the right away and neglected to innovate and all the while Lilly just kept marching on.

You don’t need thousands of reps selling Wegovy. We launched it with a couple hundred. What you needed was supply. Support. Access. Innovation.

But now it’s all too late. Nothing can be done now to change the trajectory of both Ozempic and Wegovy. The best we can do is hope that CagriSema or another asset we’ve acquired can compete.

But again, Lilly is light years ahead of us in pipeline and their next generation meds look better than our own.

Love Novo as a company, but I fear for our future.

First - thank you UberDriver for that video. It was very good and timely.

Anyone who forced themselves to sit through those town halls this week - kudos to you. I've been in the workforce for a lot of years and have never seen someone so utterly tone deaf in that time. LA gleefully telling everyone how excited they are for this new model as he's showing the cuts is deplorable. And the icing message: but we want you to apply for these breadcrumbs and be submissive. This WILL happen again within the next year.

If you're thinking of applying here - the culture they've always pushed is 100% gone. They've become desperate and it's become Another Brick in the Wall march.

Helge Lund is the jerk here. He was fired from BP. How is he the one taking decisions?

anonymous said:

Just 2 or 3 months ago Lars was talking about how the stock doesn't dictate Novo's performance.
Still sure about that?

Click to expand...

What is he supposed to say? Is management supposed to tell you that huge cuts will be coming…then you will stop working.